| Cancer vulnerabilities unveiled by genomic loss D Nijhawan, TI Zack, Y Ren, MR Strickland, R Lamothe, SE Schumacher, ... Cell 150 (4), 842-854, 2012 | 248 | 2012 |
| Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma DJH Shih, N Nayyar, I Bihun, I Dagogo-Jack, CM Gill, E Aquilanti, ... Nature genetics 52 (4), 371-377, 2020 | 231 | 2020 |
| PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling SE Moody, AC Schinzel, S Singh, F Izzo, MR Strickland, L Luo, ... Oncogene 34 (16), 2061-2071, 2015 | 114 | 2015 |
| Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer JK Sabari, V Velcheti, K Shimizu, MR Strickland, RS Heist, M Singh, ... Clinical Cancer Research 28 (15), 3318-3328, 2022 | 106 | 2022 |
| Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas MR Strickland, CM Gill, N Nayyar, MR D'Andrea, C Thiede, TA Juratli, ... Journal of neurosurgery 127 (2), 438-444, 2017 | 69 | 2017 |
| Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis PK Brastianos, MR Strickland, EQ Lee, N Wang, JV Cohen, U Chukwueke, ... Nature communications 12 (1), 5954, 2021 | 63 | 2021 |
| Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker MS Taylor, C Wu, PC Fridy, SJ Zhang, Y Senussi, JC Wolters, T Cajuso, ... Cancer discovery 13 (12), 2532-2547, 2023 | 34 | 2023 |
| Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition C Alvarez-Breckenridge, SC Markson, JH Stocking, N Nayyar, ... Cancer immunology research 10 (8), 996-1012, 2022 | 34 | 2022 |
| Tumor immune microenvironment of brain metastases: toward unlocking antitumor immunity MR Strickland, C Alvarez-Breckenridge, JF Gainor, PK Brastianos Cancer discovery 12 (5), 1199-1216, 2022 | 29 | 2022 |
| Clinical and imaging features of non-small cell lung cancer with G12C KRAS mutation MY Wu, EW Zhang, MR Strickland, DP Mendoza, L Lipkin, JK Lennerz, ... Cancers 13 (14), 3572, 2021 | 28 | 2021 |
| Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies D Mitra, JW Clark, HA Shih, KS Oh, PK Brastianos, JY Wo, MR Strickland, ... The Oncologist 24 (2), 193-201, 2019 | 23 | 2019 |
| Genomic analysis of posterior fossa meningioma demonstrates frequent AKT1 E17K mutations in foramen magnum meningiomas SR Williams, TA Juratli, BA Castro, TT Lazaro, CM Gill, N Nayyar, ... Journal of Neurological Surgery Part B: Skull Base 80 (06), 562-567, 2019 | 22 | 2019 |
| Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer M An, A Mehta, BH Min, YJ Heo, SJ Wright, M Parikh, L Bi, H Lee, TJ Kim, ... Cancer Discovery 14 (5), 766-785, 2024 | 12 | 2024 |
| DNA damage by radiopharmaceuticals and mechanisms of cellular repair Y Khazaei Monfared, P Heidari, SJ Klempner, U Mahmood, AR Parikh, ... Pharmaceutics 15 (12), 2761, 2023 | 6 | 2023 |
| Management of locally advanced rectal cancer: ASCO guideline AJ Scott, EB Kennedy, J Berlin, G Brown, M Chalabi, MT Cho, M Cusnir, ... Journal of Clinical Oncology 42 (28), 3355-3375, 2024 | 5 | 2024 |
| Gastroesophageal adenocarcinomas with defective mismatch repair: current knowledge and clinical management MR Strickland, EM Lander, MK Gibson, DH Ilson, JA Ajani, SJ Klempner Journal of the National Comprehensive Cancer Network 22 (3), 2024 | 4 | 2024 |
| Recent Advances in the Management of Anal Cancer L Upadhyay, M Hartzell, AR Parikh, MR Strickland, S Klempner, M Malla Healthcare 11 (23), 3010, 2023 | 4 | 2023 |
| Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trial M An, A Mehta, BH Min, YJ Heo, M Parikh, L Bi, R Cristescu, H Lee, T Kim, ... medRxiv, 2023.04. 03.23288062, 2023 | 2 | 2023 |
| GENE-63. GENOMIC CHARACTERIZATION OF HUMAN BRAIN METASTASES IDENTIFIES NOVEL DRIVERS OF LUNG ADENOCARCINOMA PROGRESSION N Nayyar, D Shih, I Bihun, I Dagogo-Jack, C Gill, E Aquilanti, M Bertalan, ... Neuro-Oncology 21 (Supplement_6), vi111-vi111, 2019 | 2 | 2019 |
| Clinically-actionable mutations in posterior skull base meningiomas SR Williams, BA Castro, TT Lazaro, CM Gill, N Nayyar, MP Frosch, ... Journal of Neurological Surgery Part B: Skull Base 78 (S 01), A027, 2017 | 2 | 2017 |
